1-10 of 10
Andrew J. Yee
Close
Sort by
Articles

Best of 2017 in Multiple Myeloma

Noopur Raje, MD, Andrew J. Yee, MD
Journal: The Hematologist
The Hematologist (2018) 15 (1)
https://doi.org/10.1182/hem.V15.1.8179
Published: 2018
Articles

Programming Myeloma Cell Death With Venetoclax

Noopur Raje, MD, Andrew J. Yee, MD
Journal: The Hematologist
The Hematologist (2017) 14 (6)
https://doi.org/10.1182/hem.V14.6.7792
Published: 2017
Articles

Is Upfront Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma the Standard?

Noopur Raje, MD, Andrew J. Yee, MD
Journal: The Hematologist
The Hematologist (2017) 14 (4)
https://doi.org/10.1182/hem.V14.4.7450
Published: 2017
Articles

Peripheral Blood Genomic Interrogation in Myeloma: Developing a Blood Biopsy to Replace the Bone Marrow Biopsy

Jens G. Lohr, MD, PhD, Noopur Raje, MD, Andrew J. Yee, MD
Journal: The Hematologist
The Hematologist (2017) 14 (2)
https://doi.org/10.1182/hem.V14.2.7135
Published: 2017
Articles

Practice-Changing Daratumumab Combinations for the Treatment of Multiple Myeloma

Elizabeth O'Donnell, MD, Noopur Raje, MD, Andrew J. Yee, MD
Journal: The Hematologist
The Hematologist (2017) 14 (1)
https://doi.org/10.1182/hem.V14.1.7006
Published: 2017
Articles

Checking Multiple Myeloma with Pembrolizumab

Noopur Raje, MD, Andrew J. Yee, MD
Journal: The Hematologist
The Hematologist (2016) 13 (4)
https://doi.org/10.1182/hem.V13.4.5637
Published: 2016
Articles

Novel Drugs Push the Envelope in Multiple Myeloma

Elizabeth O'Donnell, MD, Noopur Raje, MD, Andrew J. Yee, MD
Journal: The Hematologist
The Hematologist (2016) 13 (1)
https://doi.org/10.1182/hem.V13.1.4832
Published: 2016
Articles

Monoclonal Antibodies in the Treatment of Multiple Myeloma with a Focus on Elotuzumab and Daratumumab

Noopur Raje, MD, Andrew J. Yee, MD
Journal: The Hematologist
The Hematologist (2015) 12 (6)
https://doi.org/10.1182/hem.V12.6.4495
Published: 2015
Articles

Do We Need Another HDAC Inhibitor in Multiple Myeloma?

Noopur Raje, MD, Andrew J. Yee, MD
Journal: The Hematologist
The Hematologist (2015) 12 (4)
https://doi.org/10.1182/hem.V12.4.4155
Published: 2015
Articles

Transitioning to an All Oral Therapy for Multiple Myeloma with the Novel Proteasome Inhibitor Ixazomib

Noopur Raje, MD, Andrew J. Yee, MD
Journal: The Hematologist
The Hematologist (2015) 12 (2)
https://doi.org/10.1182/hem.V12.2.3679
Published: 2015